US5393192027 - Common Stock - After market: 0.7505 -0.04 (-5%)
THE RESEARCH SHOWS THAT PP2A, THE TARGET OF LIXTE’S LEAD CLINICAL COMPOUND, LB-100, WHEN DEFICIENT, ENHANCES EFFECTS OF IMMUNE CHECKPOINT BLOCKADE OF...
It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to keep a watch on Monday!
CrowdStrike (CRWD) stock is in the news Wednesday as the cybersecurity company announced Michael Sentonas as its new president.
Tripadvisor (TRIP) stock is getting a boost on Wednesday after the company got a double upgrade and new price target from Bank of America.
Alibaba (BABA) stock is on the move Wednesday as investors react to news of the company testing an AI tool to rival ChatGPT.
Lixte Biotech (LIXT) stock is dropping on Wednesday but it's not due to any negative news from the drug discovery company.
Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday!
--THE STUDY ESTABLISHES A NOVEL CONCEPT OF “TUMOR SUPPRESSIVE DRUG RESISTANCE” --THE COMBINATION OF LB-100 WITH INHIBITORS OF CELLULAR STRESS RESPONSE...
We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!
PASADENA, CA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), (“LIXTE” or the “Company”), a clinical-stage...